Company / Current Liabilities
Oric Pharmaceuticals, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$20.4M
FY2025
5-year range
$15.2M / $24.8M
FY2021-FY2025
Trend
-17.8%
vs FY2024
Sector context
#189 of 213
Health Care
What the data says
Oric Pharmaceuticals, Inc.'s current liabilities of $20M is lower than 89% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of +17.8%.
Remained stable around $20M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +9.9%
- 5-Year CAGR
- +17.8%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 213This company $20.4M Sector average $1.6B
▼
-98.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.8%, indicating consistent growth.
- In FY2025, current liabilities decreased 17.8% year-over-year.
- Ranks #189 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.4M | -17.8% |
| FY2024 | $24.8M | +21.4% |
| FY2023 | $20.5M | +32.9% |
| FY2022 | $15.4M | +1.6% |
| FY2021 | $15.2M | +68.3% |
| FY2020 | $9.0M | +68.1% |
| FY2019 | $5.4M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026